Chemoinformaics analysis of 12-Hydroxyamoorastatone
Molecular Weight | 532.586 | nRot | 2 |
Heavy Atom Molecular Weight | 496.298 | nRig | 32 |
Exact Molecular Weight | 532.231 | nRing | 6 |
Solubility: LogS | -4.116 | nHRing | 2 |
Solubility: LogP | 0.63 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 2 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 28 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
No. of Oxygen atom | 10 | No. of Arom Bond | 5 |
nHA | 10 | APOL | 78.7845 |
nHD | 4 | BPOL | 43.9275 |
QED | 0.403 |
Synth | 6.463 |
Natural Product Likeliness | 3.142 |
NR-PPAR-gamma | 0.503 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.039 |
Pgp-sub | 0.997 |
HIA | 0.702 |
CACO-2 | -5.299 |
MDCK | 0.000106227 |
BBB | 0.556 |
PPB | 0.432345 |
VDSS | 1.002 |
FU | 0.480144 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0.087 |
CYP2c19-inh | 0.002 |
CYP2c19-sub | 0.289 |
CYP2c9-inh | 0.004 |
CYP2c9-sub | 0.059 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.119 |
CYP3a4-inh | 0.052 |
CYP3a4-sub | 0.21 |
CL | 3.739 |
T12 | 0.102 |
hERG | 0.005 |
Ames | 0.059 |
ROA | 0.936 |
SkinSen | 0.011 |
Carcinogencity | 0.073 |
EI | 0.016 |
Respiratory | 0.983 |
NR-Aromatase | 0.007 |
Antiviral | Yes |
Prediction | 0.823008 |